Status:
RECRUITING
REal World Data in LYmphoma and Survival in Adults
Lead Sponsor:
Hospices Civils de Lyon
Collaborating Sponsors:
The Lymphoma Academic Research Organisation
Conditions:
Diffuse Large B Lymphoma (DLBCL)
Follicular Lymphoma (FL)
Eligibility:
All Genders
18+ years
Brief Summary
REALYSA cohort is a population-based epidemiological platform in real-life for lymphomas designed to enrich prognostic data, by integrating together epidemiological, clinical and biological data. REA...
Eligibility Criteria
Inclusion
- Signature of the consent form for participation in the REALYSA cohort
- Aged over 18 at the time of inclusion
- Diagnosed with lymphoma in the last 6 months (180 days)
- Lymphoma subtype belonging to at least one of the 7 histological subtypes: diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, marginal zone lymphoma, T-cell lymphoma, Hodgkin's lymphoma, Burkitt lymphoma
Exclusion
- Anti-lymphoma treatment already received (except pre-phase: typically corticosteroids, vincristine, cyclophosphamide, etoposide, alone or in combination)
- Documented HIV infection
- Any other lymphoma subtype not included in the list in Appendix 1. Of note, are excluded:
- Chronic lymphocytic leukemia/small lymphocytic lymphoma
- Hairy cell leukemia and variant
- Lymphoplasmacytic lymphoma
- Waldenström macroglobulinemia
- Primary DLBCL of the central nervous system (CNS)
- T-cell large granular lymphocytic leukemia
- Chronic lymphoproliferative disorder of NK cells
- Mycosis fungoides
- Sézary syndrome
- Primary cutaneous T cell lymphomas (mainly diagnosed and treated by dermatologists)
- Post-transplant lymphoproliferative disorders (PTLD)
Key Trial Info
Start Date :
November 14 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 14 2027
Estimated Enrollment :
6000 Patients enrolled
Trial Details
Trial ID
NCT03869619
Start Date
November 14 2018
End Date
November 14 2027
Last Update
June 28 2021
Active Locations (37)
Enter a location and click search to find clinical trials sorted by distance.
1
Unité d'Hématologie Clinique, CH D'ARRAS
Arras, France, 62022
2
Service d'Hématologie, CHU Jean Minjoz
Besançon, France, 25030
3
Service d'Onco-radiolothérapie, Polyclinique Bordeaux Nord Aquitaine
Bordeaux, France, 33300
4
Institut Bergonié
Bordeaux, France